Dr. Kelley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
69 Jesse Hill Jr Dr SE
Atlanta, GA 30303Phone+1 404-616-3603Fax+1 404-616-8605
Education & Training
- Emory University School of MedicineFellowship, Infectious Disease, 2007 - 2010
- University of California (San Francisco)Residency, Internal Medicine, 2004 - 2007
- Emory University School of MedicineClass of 2004
- University of FloridaB.A., English, Cum Laude, 1998
Certifications & Licensure
- CA State Medical License 2005 - Present
- GA State Medical License 2007 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Atlanta Rotary Fellow in Health Research 2013
- Provider of the month Grady Infectious Disease Program, 2011
- Virology Fellow Bristol Myers Squibb, 2009
- Join now to see all
Clinical Trials
- Systems Biology of PNEUMOVAX®23 and PREVNAR 13® Start of enrollment: 2014 Apr 01
- Systems Biology of Flu Vaccine in Healthy Adults With and Without the Use of Antibiotics Start of enrollment: 2015 Apr 01
- Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities Start of enrollment: 2017 Feb 06
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsImpact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome.Victoria T Chu, Abigail Glascock, Deborah Donnell, Cole Grabow, Clare E Brown
Nature Medicine. 2025-01-01 - Rectal mucosal inflammation, microbiome, and wound healing in men who have sex with men who engage in receptive anal intercourse.Vanessa E Van Doren, Cassie G Ackerley, Robert A Arthur, Phillip M Murray, S Abigail Smith
Scientific Reports. 2024-12-30 - HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines.Gregory J Wilson, L W Preston Church, Colleen F Kelley, Samuel T Robinson, Yiwen Lu
The Journal of Infectious Diseases. 2024-12-13
Journal Articles
- Applying a PrEP Care Continuum for Men who Have Sex with Men in Atlanta, GAKelley CF, Kahle E, Siegler AS, Sanchez T, del Rio C, Sullivan PS, Rosenberg ES, Clinical Infectious Diseases, 1/15/2015
- On-Demand Pre-exposure Prophylaxis in Men at High Risk for HIV-1 InfectionMolina et al, New England Journal of Medicine Open Forum, 1/8/2015
- Heterogeneity of HIV Prevalence Among the Sexual Networks of Black and White Men Who Have Sex with Men in Atlanta: Illuminating a Mechanisma for Increased HIV Risk for...Hernandez-Romieu AC, Sullivan PS, Rothenberg R, Grey J, Luisi N, Kelley CF, Rosenberg ES, Sexually Transmitted Diseases, 1/1/2015
- Join now to see all
Lectures
- Barriers to Effective Prevention: Applying a PrEP Care Continuum to a US Cohort of Black and White MSMSeattle, WA - 1/5/2015
- Pre-exposure Prophylaxis (PrEP) for Men who Have Sex with Men (MSM)Bangkok, Thailand - 1/3/2015
- Understanding Rectal Transmission of HIVBangkok, Thailand - 1/3/2015
- Join now to see all
Press Mentions
- Clinical Trial Reveals Twice-Yearly Injection to Be 96% Effective in HIV PreventionDecember 4th, 2024
- Incidence of HIV Lower with Twice-Yearly Subcutaneous LenacapavirDecember 4th, 2024
- New HIV Prevention Injection Offers 96% ProtectionNovember 28th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: